The R&D pharma company Accure Therapeutics, a member of CATALONIA.HEALTH, has received two grants totalling 1.6 million of dollars, $1.12M in grants awarded by The Michael J. Fox Foundation (MJFF) and $0.48M by the Luxembourg National Research Fund (FNR) for two separate development programs on its drug candidate ACT-02.

The venture capital company Ysios Capital, a member of CATALONIA.HEALTH, has announced that its investee company, Neurona Therapeutics, has closed a funding round of 102 million dollars. 

The CEO of the biotech company specialized in enhancing the female fertility, Oxolife, a member of CATALONIA.HEALTH, Agnès Arbat, wins the 2025 European Prize for Women Innovators in the Women Innovator category. 

Biotechnology company Gain Therapeutics, member of CATALONIA.HEALTH, announce the dosing of the first participant with Parkinson’s disease in its Phase 1b clinical trial of GT-02287

Biotech company Nuage Therapeutics, member of CATALONIA.HEALTH, has announced the appointment of Stuart Hughes as Chief Executive Officer and Vanessa Malier as Chair of the Board of Directors.

The pharmaceutical company Reig Jofre, a member of CATALONIA.HEALTH, has signed a commercial agreement with LEO Pharma, with the aim to strengthen the promotion of LEO Pharma’s innovative treatment for mild to moderate psoriasis within the scope of Primary Care in Spain.

Asabys Partners, a member of CATALONIA.HEALTH, has announced that its investee Augustine Therapeutics, has closed a Series A financing round, raising a total of 85 million dollars. 

i4KIDS, the Paediatric Innovation Hub at Sant Joan de Déu Barcelona Children's Hospital, member of CATALONIA.HEALTH, has been awarded the National Award for Knowledge Transfer Promotion 2024 by the Catalan Foundation for Research and Innovation (FCRI) and the Government of Catalonia. 

The technological company Neos Surgery, a member of CATALONIA.HEALTH, has received the Innovation Award at the VIII edition of the Spanish SME of the Year Award 2024, held in Madrid. 

The gene therapy biotechnology company SpliceBio, a member of CATALONIA.HEALTH, announced that it has dosed the first patient in the Phase 1/2 ASTRA study of SB-007, a dual adeno-associated viral (AAV) vector, for the treatment of Stargardt disease.

The health sector plays a key role in the digital world we live in. That is why digital health has had an important place at the 2025 edition of 4YFN, the event parallel to the Mobile World Congress (MWC), which is a benchmark for the international entrepreneurial ecosystem, and that is why CATALONIA.HEALTH was there to showcase examples of the best local medical device technologies. CATALONIA.HEALTH successfully met a new challenge, as it participated in this event for the first time.

The biotech company CONNECTA Therapeutics, a member of CATALONIA.HEALTH, has announced positive results from its Phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics profile of its drug candidate CTH120 in adult volunteers.

The biotech company Ona Therapeutics, a member of CATALONIA.HEALTH, announced key leadership appointments in their leadership team to support its rapid growth and pipeline advancement.

The DeepTech company Devshealth’s CEO Alfons Nonell-Canals, member of CATALONIA.HEALTH, has been elected as a member of the BEAM Alliance Board of Directors during the recent AMR conference. 

The pharmaceutical company Reig Jofre, a member of CATALONIA.HEALTH, reinforces its dermatology business with the launch of Vincobiosis® Acneic, an innovative range of topical products that blend science and nature to effectively and gently manage acne-prone skin.

The advanced therapeutics company Integra Therapeutics moves its headquarters to the new Advanced Therapies Platform at SJD Barcelona Children's Hospital, both members of CATALONIA.HEALTH. 

The Vall d’Hebron Research Institute (VHIR), a member of CATALONIA.HEALTH, has implemented a new innovation model to reshape how biomedical research impacts society.

The biotech company Zymvol, a member of CATALONIA.HEALTH, has raised a seed funding of €3M. It was led by venture capital firms Faber Ventures (lead investor), Elaia Partners (existing pre-seed investor), and Übermorgen Ventures.

The Hospital Sant Joan de Déu Barcelona and Oxolife have received the CATALONIA.HEALTH 2025 Award (formerly Bioèxit) during the 11th edition of the Nit, the annual event of reference in the field of health and life sciences in Catalonia, organised by CATALONIA.HEALTH and life sciences in Catalonia, organised by CATALONIA.HEALTH. The award recognises relevant trajectories and projects based on the axes of innovation, science and business, and which stand out for their excellence in areas such as scientific innovation, industrialization innovation, industrialisation, regulatory milestones and international expansion.

CATALONIA.HEALTH has repeated its collaboration with Tech Spirit Barcelona, the annual event promoted by Tech Barcelona, which showcases the city's up-and-coming technology scene. This year's edition once again brought together medical professionals, health technologists, pharmaceutical leaders and entrepreneurs in a dynamic convergence of innovators who are redefining the landscape of healthcare delivery and accessibility, demonstrating the drive for change in the future of healthcare.